News
Eisai sets Leqembi price in Japan at a discount to US
Eisai and Biogen’s Alzheimer’s disease therapy Leqembi is due to be …
19770 items found
Digital
Prescription digital therapeutics show tremendous promise to improve - and save - lives
If you’re reading headlines out of Washington, DC, it can feel like …
News
Daiichi Sankyo taps Depixus to speed RNA drug discovery
Daiichi Sankyo has made the development of RNA-based therapeutics and …
News
Final obstacles in front of Pfizer, Seagen merger fall
Pfizer is expecting to close its $43 billion acquisition of …
Digital
Responsible integration of AI in pharmaceutical labs
As applications of generative AI (GenAI), and AI in general, extend …
News
Genentech confirms Magargee as permanent CEO
Roche’s Genentech unit has looked internally for its new chief …
Sales & Marketing
Sponsored
Coaching and Medical Affairs: The View from the Frontline
Medical Affairs is consolidating its position as a critical pillar of …
News
Digitised pathology resource will speed HIV cancer R&D
A collection of clinical specimens that has been gathered from people …
News
BMS bolts on SystImmune bispecific ADC in $8.4bn deal
The litany of big-ticket deals involving antibody-drug conjugates …
R&D
Is the future of pharmaceutical drugs in the delivery?
Pharmaceutical drugs have seen a seismic shift over the past ten …
News
AZ agrees $1.1bn deal to buy RSV jab developer Icosavax
Not content with taking on the respiratory syncytial virus (RSV) …
Digital
Retaining the human element in healthcare services whilst embracing the potential of robotics
In a new episode of the pharmaphorum podcast, web editor Nicole …
News
Nasdaq debutante Septerna swells its IPO to $331m
Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount raised topping $331 million.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
